Sponsored by:

Moly crisis to continue as AECL pushes reactor restart to 2010

Aug 12, 2009

Nuclear medicine physicians may have to wait a little longer for the shortage of the radioisotope molybdenum-99 to abate. Atomic Energy of Canada (AECL) has pushed back the anticipated restart of its Chalk River, Ontario, nuclear reactor to the first quarter of 2010.

Click here to read the rest of the article.

Latest in Nuclear Medicine
2025 01 08 Ssr2 Thumbnail
Theranostic pair ready for testing in lung cancer
January 8, 2026
Handshake
Archeus Technologies names new slate of executives
January 7, 2026
Delivering PET radiopharmaceuticals to advance patient outcomes
Sponsored
Delivering PET radiopharmaceuticals to advance patient outcomes
January 1, 2026
Business Handshake 400
AtomVie signs supply agreement with Ionetix for Ac-225 development
December 18, 2025
Related Stories
2009 08 12 13 36 02 745 Pet Market Siemens Thumb
Nuclear Medicine
U.S. PET sales drop 17% in 2008, but optimism remains
2009 07 31 14 50 21 466 2009 08 03 Neuroblast Thumb
Nuclear Medicine
FDG-PET best for early detection of neuroblastoma
2009 07 29 11 16 21 770 Hacker Image01 Thumb
Nuclear Medicine
Dual-source CTA turns in mixed results for coronary stenoses
Delivering PET radiopharmaceuticals to advance patient outcomes
Sponsor Content
Delivering PET radiopharmaceuticals to advance patient outcomes
More in Nuclear Medicine
Theranostic pair ready for testing in lung cancer
By Will Morton
Gallium-68 (Ga-68) SSO120 PET/CT successfully visualized lesions in patients during and after chemotherapy.
January 8, 2026
2025 01 08 Ssr2 Thumbnail
Archeus Technologies names new slate of executives
By AuntMinnie.com staff writers
The new team will lead the company as it enters its next stage of clinical growth.
January 7, 2026
Handshake
Niowave expands supply agreement with AstraZeneca
By AuntMinnie.com staff writers
Niowave is expanding its supply agreement with AstraZeneca to a 10-year commitment to deliver actinium-225.
December 18, 2025
Manufacturing Facility Process 400
AtomVie signs supply agreement with Ionetix for Ac-225 development
By AuntMinnie.com staff writers
AtomVie has entered a strategic partnership with Ionetix for the development of actinium-225 (Ac-225) for AtomVie's partners worldwide.
December 18, 2025
Business Handshake 400
RadioMedix secures Th-228 supply
By AuntMinnie.com staff writers
The supply will support the company's advancing cancer therapeutics pipeline.
December 17, 2025
Isotopes1
UCLA to launch department of nuclear medicine and theranostics
By AuntMinnie.com staff writers
The University of California, Los Angeles (UCLA) will open a department of nuclear medicine and theranostics on January 1, 2026.
November 19, 2025
Nuclearmedicine
Cardiology network extends adoption of GEHC's Flyrcado
By AuntMinnie.com staff writers
After a successful pilot, Cardiovascular Associates of America plans to expand adoption of GEHC's radiotracer Flyrcado.
November 19, 2025
Pet Scanner Bore 400
Siemens Healthineers rebrands radiopharmaceutical companies
By AuntMinnie.com staff writers
Siemens Healthineers has rebranded PETNet Solutions and AdAcAp Molecular Imaging as its radiopharma business segment.
November 18, 2025
Siemens Rsna 2021 400
Global initiative to guide NMTs in theranostics
By AuntMinnie.com staff writers
The responsibilities of nuclear medicine technologists (NMTs) in theranostics are evolving rapidly.
October 29, 2025
Isotopes1
LLMs rapidly evolving in nuclear medicine
By Will Morton
Large language models (LLMs) are widely used to handle the large volume of text data generated in nuclear medicine.
October 24, 2025
Ai Hand
Telix's Zircaix included in society guidelines for renal imaging
By AuntMinnie.com staff writers
Telix welcomes updated guidelines from medical societies for including TLX250-CDx (Zircaix) for imaging renal masses.
October 23, 2025
Kidneys 400
Andrew Trout tapped to lead radiology at Cincinnati Children's
By AuntMinnie.com staff writers
Trout served as director of nuclear medicine at Cincinnati Children’s from 2016 through 2024.
October 17, 2025
Andrew Trout, MD
Page 1 of 440
Next Page